Suppr超能文献

高敏C反应蛋白水平能否预测腰椎间盘疾病患者硬膜外类固醇注射后的功能结局?

Can High-Sensitivity C-Reactive Protein Levels Predict Functional Outcome Following Epidural Steroid Injection in Patients with Lumbar Disc Disease?

作者信息

Gopireddy Rajesh, Rangasamy Karthick, Goni Vijay G, Vatsya Pulak, Behera Prateek, Batra Yatindra K, Vaishnavi Chetana

机构信息

Department of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Department of Orthopaedics, All India Institute of Medical Sciences (New Delhi), New Delhi, India.

出版信息

Asian Spine J. 2021 Dec;15(6):753-760. doi: 10.31616/asj.2020.0295. Epub 2020 Dec 28.

Abstract

STUDY DESIGN

Prospective cohort study.

PURPOSE

Inflammatory cytokines produced at the site of disc herniation are considered as pain generators in patients with lumbar disc disease. Whether a high-sensitivity C-reactive protein (hs-CRP) assay can be used in order to predict the quantum of inflammation surrounding nerve roots is a matter of investigation. This study aimed to evaluate the association of hs-CRP level and functional outcomes measured by the Modified Oswestry Low Back Pain Disability Questionnaire (MODY) before and after epidural steroid injection (ESI) in patients with lumbar disc disease.

OVERVIEW OF LITERATURE

Although many studies examining the role of hs-CRP levels and lumbar pain have been published previously, the results are equivocal, and there is no clear consensus regarding which patients will benefit from an ESI.

METHODS

This was a prospective study, with 77 patients in the study group and 23 participants in the control group. Baseline hs-CRP levels were obtained for both groups. Study group patients received a single ESI and were subjected to detailed pre- and postprocedure evaluation using MODY scores. For this group, hs-CRP levels were measured at 1 and 2 months after injection.

RESULTS

Out of 77 patients, 52 had acute and 25 had chronic low back pain. Thirty-six patients with acute pain obtained significant improvement, while 16 had an insignificant response to the ESI. None of the chronic cases had a significant response. The mean baseline hs-CRP (mg/L) among the study group (29.83±10.43) was significantly higher than for the controls (10.26±2.783). The baseline hs-CRP among acute cases, where post ESI MODY score at 2 months had significant reduction, was 32.19±5.126, and those with insignificant reduction was 18.13±7.949 (p<0.001).

CONCLUSIONS

Baseline hs-CRP levels can be used to prognosticate the outcome following ESI in patients with acute lumbar disc disease, with radicular pain refractory to physiotherapy and analgesics.

摘要

研究设计

前瞻性队列研究。

目的

椎间盘突出部位产生的炎性细胞因子被认为是腰椎间盘疾病患者的疼痛根源。高敏C反应蛋白(hs-CRP)检测能否用于预测神经根周围的炎症程度尚待研究。本研究旨在评估腰椎间盘疾病患者硬膜外类固醇注射(ESI)前后hs-CRP水平与改良奥斯维斯特里腰痛残疾问卷(MODY)所测量的功能结果之间的关联。

文献综述

尽管此前已发表了许多研究hs-CRP水平与腰痛作用的文章,但其结果并不明确,对于哪些患者将从ESI中获益也没有明确的共识。

方法

这是一项前瞻性研究,研究组有77例患者,对照组有23名参与者。两组均获取基线hs-CRP水平。研究组患者接受单次ESI,并使用MODY评分进行详细的术前和术后评估。对于该组,在注射后1个月和2个月测量hs-CRP水平。

结果

77例患者中,52例有急性腰痛,25例有慢性腰痛。36例急性疼痛患者有显著改善,而16例对ESI反应不明显。慢性病例均无显著反应。研究组的平均基线hs-CRP(mg/L)(29.83±10.43)显著高于对照组(10.26±2.783)。2个月时ESI后MODY评分显著降低的急性病例的基线hs-CRP为32.19±5.126,而降低不明显的病例为18.13±7.949(p<0.001)。

结论

基线hs-CRP水平可用于预测急性腰椎间盘疾病患者在接受ESI后的结果,这些患者患有对物理治疗和镇痛药无效的神经根性疼痛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff8b/8696050/b5692829b98c/asj-2020-0295f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验